Wed, Nov 26, 2014, 10:04 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Novo Nordisk A/S Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • magmacity1 magmacity1 Nov 8, 2012 3:58 PM Flag

    Finally!! Up to max

    Some findings for sure. Nov 8 (Reuters) - Novo Nordisk A/S : * Hypoglycemia risk of Novo nordisk's degludec insulin in trials did

    not appear significantly higher or lower than oher insulins -- chair of FDA

    advisory panel * Balance seemed reasonable between efficacy and hypoglycemia in studies of

    degludec - chair of FDA advisory panel * 24-hr half life of degludec makes it unique in terms of long, stable

    duration, dosing flexibility - chair of FDA advisory panel

    Sentiment: Strong Buy

 
NVO
44.93+0.26(+0.58%)Nov 26 4:03 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.